New hope for ALS: NUZ-001 drug enters major trial
Disease control
ENROLLING_BY_INVITATION
This study tests a drug called NUZ-001 in 160 people with ALS, a disease that weakens muscles over time. The goal is to see if the drug can slow the disease and help people live longer. Participants take the drug and are monitored for changes in movement, breathing, and survival.
Phase: PHASE2, PHASE3 • Sponsor: Merit E. Cudkowicz, MD • Aim: Disease control
Last updated May 01, 2026 15:58 UTC